table of content
1 Introduction to Research & Analysis Reports
1.1 Veterinary Biologics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Veterinary Biologics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Veterinary Biologics Overall Market Size
2.1 Global Veterinary Biologics Market Size: 2022 VS 2030
2.2 Global Veterinary Biologics Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Veterinary Biologics Sales: 2018-2030
3 Company Landscape
3.1 Top Veterinary Biologics Players in Global Market
3.2 Top Global Veterinary Biologics Companies Ranked by Revenue
3.3 Global Veterinary Biologics Revenue by Companies
3.4 Global Veterinary Biologics Sales by Companies
3.5 Global Veterinary Biologics Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Veterinary Biologics Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Veterinary Biologics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Veterinary Biologics Players in Global Market
3.8.1 List of Global Tier 1 Veterinary Biologics Companies
3.8.2 List of Global Tier 2 and Tier 3 Veterinary Biologics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Veterinary Biologics Market Size Markets, 2022 & 2030
4.1.2 Vaccines
4.1.3 Monoclonal Antibodies
4.2 By Type - Global Veterinary Biologics Revenue & Forecasts
4.2.1 By Type - Global Veterinary Biologics Revenue, 2018-2023
4.2.2 By Type - Global Veterinary Biologics Revenue, 2024-2030
4.2.3 By Type - Global Veterinary Biologics Revenue Market Share, 2018-2030
4.3 By Type - Global Veterinary Biologics Sales & Forecasts
4.3.1 By Type - Global Veterinary Biologics Sales, 2018-2023
4.3.2 By Type - Global Veterinary Biologics Sales, 2024-2030
4.3.3 By Type - Global Veterinary Biologics Sales Market Share, 2018-2030
4.4 By Type - Global Veterinary Biologics Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Veterinary Biologics Market Size, 2022 & 2030
5.1.2 Llivestock
5.1.3 Equine
5.1.4 Other
5.2 By Application - Global Veterinary Biologics Revenue & Forecasts
5.2.1 By Application - Global Veterinary Biologics Revenue, 2018-2023
5.2.2 By Application - Global Veterinary Biologics Revenue, 2024-2030
5.2.3 By Application - Global Veterinary Biologics Revenue Market Share, 2018-2030
5.3 By Application - Global Veterinary Biologics Sales & Forecasts
5.3.1 By Application - Global Veterinary Biologics Sales, 2018-2023
5.3.2 By Application - Global Veterinary Biologics Sales, 2024-2030
5.3.3 By Application - Global Veterinary Biologics Sales Market Share, 2018-2030
5.4 By Application - Global Veterinary Biologics Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Veterinary Biologics Market Size, 2022 & 2030
6.2 By Region - Global Veterinary Biologics Revenue & Forecasts
6.2.1 By Region - Global Veterinary Biologics Revenue, 2018-2023
6.2.2 By Region - Global Veterinary Biologics Revenue, 2024-2030
6.2.3 By Region - Global Veterinary Biologics Revenue Market Share, 2018-2030
6.3 By Region - Global Veterinary Biologics Sales & Forecasts
6.3.1 By Region - Global Veterinary Biologics Sales, 2018-2023
6.3.2 By Region - Global Veterinary Biologics Sales, 2024-2030
6.3.3 By Region - Global Veterinary Biologics Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Veterinary Biologics Revenue, 2018-2030
6.4.2 By Country - North America Veterinary Biologics Sales, 2018-2030
6.4.3 US Veterinary Biologics Market Size, 2018-2030
6.4.4 Canada Veterinary Biologics Market Size, 2018-2030
6.4.5 Mexico Veterinary Biologics Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Veterinary Biologics Revenue, 2018-2030
6.5.2 By Country - Europe Veterinary Biologics Sales, 2018-2030
6.5.3 Germany Veterinary Biologics Market Size, 2018-2030
6.5.4 France Veterinary Biologics Market Size, 2018-2030
6.5.5 U.K. Veterinary Biologics Market Size, 2018-2030
6.5.6 Italy Veterinary Biologics Market Size, 2018-2030
6.5.7 Russia Veterinary Biologics Market Size, 2018-2030
6.5.8 Nordic Countries Veterinary Biologics Market Size, 2018-2030
6.5.9 Benelux Veterinary Biologics Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Veterinary Biologics Revenue, 2018-2030
6.6.2 By Region - Asia Veterinary Biologics Sales, 2018-2030
6.6.3 China Veterinary Biologics Market Size, 2018-2030
6.6.4 Japan Veterinary Biologics Market Size, 2018-2030
6.6.5 South Korea Veterinary Biologics Market Size, 2018-2030
6.6.6 Southeast Asia Veterinary Biologics Market Size, 2018-2030
6.6.7 India Veterinary Biologics Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Veterinary Biologics Revenue, 2018-2030
6.7.2 By Country - South America Veterinary Biologics Sales, 2018-2030
6.7.3 Brazil Veterinary Biologics Market Size, 2018-2030
6.7.4 Argentina Veterinary Biologics Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Veterinary Biologics Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Veterinary Biologics Sales, 2018-2030
6.8.3 Turkey Veterinary Biologics Market Size, 2018-2030
6.8.4 Israel Veterinary Biologics Market Size, 2018-2030
6.8.5 Saudi Arabia Veterinary Biologics Market Size, 2018-2030
6.8.6 UAE Veterinary Biologics Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Veterinary Biologics Major Product Offerings
7.1.4 Merck Veterinary Biologics Sales and Revenue in Global (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Zoetis
7.2.1 Zoetis Company Summary
7.2.2 Zoetis Business Overview
7.2.3 Zoetis Veterinary Biologics Major Product Offerings
7.2.4 Zoetis Veterinary Biologics Sales and Revenue in Global (2018-2023)
7.2.5 Zoetis Key News & Latest Developments
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Company Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Veterinary Biologics Major Product Offerings
7.3.4 Boehringer Ingelheim Veterinary Biologics Sales and Revenue in Global (2018-2023)
7.3.5 Boehringer Ingelheim Key News & Latest Developments
7.4 Ceva
7.4.1 Ceva Company Summary
7.4.2 Ceva Business Overview
7.4.3 Ceva Veterinary Biologics Major Product Offerings
7.4.4 Ceva Veterinary Biologics Sales and Revenue in Global (2018-2023)
7.4.5 Ceva Key News & Latest Developments
7.5 CAHIC
7.5.1 CAHIC Company Summary
7.5.2 CAHIC Business Overview
7.5.3 CAHIC Veterinary Biologics Major Product Offerings
7.5.4 CAHIC Veterinary Biologics Sales and Revenue in Global (2018-2023)
7.5.5 CAHIC Key News & Latest Developments
7.6 HVRI
7.6.1 HVRI Company Summary
7.6.2 HVRI Business Overview
7.6.3 HVRI Veterinary Biologics Major Product Offerings
7.6.4 HVRI Veterinary Biologics Sales and Revenue in Global (2018-2023)
7.6.5 HVRI Key News & Latest Developments
7.7 Ringpu Biology
7.7.1 Ringpu Biology Company Summary
7.7.2 Ringpu Biology Business Overview
7.7.3 Ringpu Biology Veterinary Biologics Major Product Offerings
7.7.4 Ringpu Biology Veterinary Biologics Sales and Revenue in Global (2018-2023)
7.7.5 Ringpu Biology Key News & Latest Developments
7.8 Yebio
7.8.1 Yebio Company Summary
7.8.2 Yebio Business Overview
7.8.3 Yebio Veterinary Biologics Major Product Offerings
7.8.4 Yebio Veterinary Biologics Sales and Revenue in Global (2018-2023)
7.8.5 Yebio Key News & Latest Developments
7.9 DHN
7.9.1 DHN Company Summary
7.9.2 DHN Business Overview
7.9.3 DHN Veterinary Biologics Major Product Offerings
7.9.4 DHN Veterinary Biologics Sales and Revenue in Global (2018-2023)
7.9.5 DHN Key News & Latest Developments
7.10 WINSUN
7.10.1 WINSUN Company Summary
7.10.2 WINSUN Business Overview
7.10.3 WINSUN Veterinary Biologics Major Product Offerings
7.10.4 WINSUN Veterinary Biologics Sales and Revenue in Global (2018-2023)
7.10.5 WINSUN Key News & Latest Developments
7.11 Elanco/Eli Lilly
7.11.1 Elanco/Eli Lilly Company Summary
7.11.2 Elanco/Eli Lilly Veterinary Biologics Business Overview
7.11.3 Elanco/Eli Lilly Veterinary Biologics Major Product Offerings
7.11.4 Elanco/Eli Lilly Veterinary Biologics Sales and Revenue in Global (2018-2023)
7.11.5 Elanco/Eli Lilly Key News & Latest Developments
7.12 Virbac
7.12.1 Virbac Company Summary
7.12.2 Virbac Veterinary Biologics Business Overview
7.12.3 Virbac Veterinary Biologics Major Product Offerings
7.12.4 Virbac Veterinary Biologics Sales and Revenue in Global (2018-2023)
7.12.5 Virbac Key News & Latest Developments
7.13 Jinyu Bio-Technology
7.13.1 Jinyu Bio-Technology Company Summary
7.13.2 Jinyu Bio-Technology Veterinary Biologics Business Overview
7.13.3 Jinyu Bio-Technology Veterinary Biologics Major Product Offerings
7.13.4 Jinyu Bio-Technology Veterinary Biologics Sales and Revenue in Global (2018-2023)
7.13.5 Jinyu Bio-Technology Key News & Latest Developments
7.14 ChengDu Tecbond
7.14.1 ChengDu Tecbond Company Summary
7.14.2 ChengDu Tecbond Business Overview
7.14.3 ChengDu Tecbond Veterinary Biologics Major Product Offerings
7.14.4 ChengDu Tecbond Veterinary Biologics Sales and Revenue in Global (2018-2023)
7.14.5 ChengDu Tecbond Key News & Latest Developments
7.15 CAVAC
7.15.1 CAVAC Company Summary
7.15.2 CAVAC Business Overview
7.15.3 CAVAC Veterinary Biologics Major Product Offerings
7.15.4 CAVAC Veterinary Biologics Sales and Revenue in Global (2018-2023)
7.15.5 CAVAC Key News & Latest Developments
7.16 Kyoto Biken
7.16.1 Kyoto Biken Company Summary
7.16.2 Kyoto Biken Business Overview
7.16.3 Kyoto Biken Veterinary Biologics Major Product Offerings
7.16.4 Kyoto Biken Veterinary Biologics Sales and Revenue in Global (2018-2023)
7.16.5 Kyoto Biken Key News & Latest Developments
7.17 FATRO
7.17.1 FATRO Company Summary
7.17.2 FATRO Business Overview
7.17.3 FATRO Veterinary Biologics Major Product Offerings
7.17.4 FATRO Veterinary Biologics Sales and Revenue in Global (2018-2023)
7.17.5 FATRO Key News & Latest Developments
7.18 Vaksindo
7.18.1 Vaksindo Company Summary
7.18.2 Vaksindo Business Overview
7.18.3 Vaksindo Veterinary Biologics Major Product Offerings
7.18.4 Vaksindo Veterinary Biologics Sales and Revenue in Global (2018-2023)
7.18.5 Vaksindo Key News & Latest Developments
7.19 Bio-Labs
7.19.1 Bio-Labs Company Summary
7.19.2 Bio-Labs Business Overview
7.19.3 Bio-Labs Veterinary Biologics Major Product Offerings
7.19.4 Bio-Labs Veterinary Biologics Sales and Revenue in Global (2018-2023)
7.19.5 Bio-Labs Key News & Latest Developments
7.20 Avimex Animal
7.20.1 Avimex Animal Company Summary
7.20.2 Avimex Animal Business Overview
7.20.3 Avimex Animal Veterinary Biologics Major Product Offerings
7.20.4 Avimex Animal Veterinary Biologics Sales and Revenue in Global (2018-2023)
7.20.5 Avimex Animal Key News & Latest Developments
8 Global Veterinary Biologics Production Capacity, Analysis
8.1 Global Veterinary Biologics Production Capacity, 2018-2030
8.2 Veterinary Biologics Production Capacity of Key Manufacturers in Global Market
8.3 Global Veterinary Biologics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Veterinary Biologics Supply Chain Analysis
10.1 Veterinary Biologics Industry Value Chain
10.2 Veterinary Biologics Upstream Market
10.3 Veterinary Biologics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Veterinary Biologics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
